For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Flavoxate hydrochloride - Overactive bladder (adults)
PAD Profile : Flavoxate hydrochloride - Overactive bladder (adults)
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Darifenacin hydrobromide
- Oxybutynin
- Propiverine hydrochloride
- Solifenacin
- Mirabegron
- Fesoterodine fumarate
- Trospium chloride
- Tolterodine
- Imipramine hydrochloride
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The APC supports patients in trialling a treatment break of their overactive bladder medicines.
A "Leaflet for trial of stopping anticholinergics" can be found in the documents section.
Flavoxate is non-formulary.
Solifenacin is the 1st line treatment option.
Tolterodine immediate release tablets or Trospium are 2nd line options in patients for whom solifenacin is not suitable.
Flavoxate is not recommended for treating overactive bladder in line with NICE NG123 - guidance can be found below